Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$69.91 - $75.81 $2.64 Million - $2.86 Million
-37,733 Reduced 99.96%
15 $1,000
Q1 2023

May 12, 2023

BUY
$63.15 - $71.6 $14,713 - $16,682
233 Added 0.62%
37,748 $2.62 Million
Q4 2022

Feb 14, 2023

BUY
$54.21 - $70.44 $77,953 - $101,292
1,438 Added 3.99%
37,515 $2.54 Million
Q3 2022

Nov 14, 2022

SELL
$53.02 - $135.75 $225,016 - $576,123
-4,244 Reduced 10.53%
36,077 $1.98 Million
Q2 2022

Aug 11, 2022

BUY
$59.26 - $71.14 $305,485 - $366,726
5,155 Added 14.66%
40,321 $2.66 Million
Q1 2022

May 16, 2022

BUY
$55.72 - $67.12 $282,556 - $340,365
5,071 Added 16.85%
35,166 $2.33 Million
Q4 2021

Feb 14, 2022

BUY
$54.02 - $63.83 $108,472 - $128,170
2,008 Added 7.15%
30,095 $1.75 Million
Q3 2021

Nov 12, 2021

BUY
$55.56 - $60.79 $18,001 - $19,695
324 Added 1.17%
28,087 $1.69 Million
Q2 2021

Aug 17, 2021

BUY
$48.42 - $60.18 $152,280 - $189,266
3,145 Added 12.78%
27,763 $1.66 Million
Q1 2021

May 14, 2021

BUY
$47.16 - $54.44 $21,033 - $24,280
446 Added 1.85%
24,618 $1.23 Million
Q4 2020

Feb 12, 2021

SELL
$48.52 - $58.02 $21,348 - $25,528
-440 Reduced 1.79%
24,172 $1.21 Million
Q3 2020

Nov 13, 2020

BUY
$53.07 - $61.1 $78,012 - $89,817
1,470 Added 6.35%
24,612 $1.35 Million
Q2 2020

Aug 14, 2020

BUY
$43.1 - $55.31 $36,635 - $47,013
850 Added 3.81%
23,142 $1.22 Million
Q1 2020

May 14, 2020

SELL
$37.79 - $51.33 $113,370 - $153,990
-3,000 Reduced 11.86%
22,292 $996,000
Q4 2019

Feb 10, 2020

BUY
$42.46 - $50.46 $14,266 - $16,954
336 Added 1.35%
25,292 $1.26 Million
Q3 2019

Nov 14, 2019

SELL
$40.12 - $45.47 $46,378 - $52,563
-1,156 Reduced 4.43%
24,956 $1.11 Million
Q2 2019

Jul 24, 2019

BUY
$37.28 - $41.68 $43,207 - $48,307
1,159 Added 4.64%
26,112 $1.08 Million
Q1 2019

May 15, 2019

SELL
$35.49 - $43.02 $76,090 - $92,234
-2,144 Reduced 7.91%
24,953 $1.01 Million
Q4 2018

Feb 14, 2019

BUY
$36.86 - $41.49 $77,258 - $86,963
2,096 Added 8.38%
27,097 $1.03 Million
Q3 2018

Nov 13, 2018

SELL
$34.76 - $39.72 $23,358 - $26,691
-672 Reduced 2.62%
25,001 $990,000
Q2 2018

Aug 14, 2018

BUY
$34.55 - $37.05 $32,027 - $34,345
927 Added 3.75%
25,673 $901,000
Q1 2018

May 14, 2018

SELL
$32.97 - $36.63 $42,663 - $47,399
-1,294 Reduced 4.97%
24,746 $866,000
Q4 2017

Feb 12, 2018

BUY
$32.09 - $34.78 $54,873 - $59,473
1,710 Added 7.03%
26,040 $904,000
Q3 2017

Nov 14, 2017

BUY
$28.96 - $34.0 $58,006 - $68,102
2,003 Added 8.97%
24,330 $824,000
Q2 2017

Aug 14, 2017

BUY
N/A
22,327
22,327 $761,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $233B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Logan Capital Management Inc Portfolio

Follow Logan Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Logan Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Logan Capital Management Inc with notifications on news.